• Explore /
  • Poster
  • / Myeloablative busulfan/melphalan (BuMel) consolidation following induction chemotherapy for patients with high-risk neuroblastoma: A Children’s Oncology Group (COG) study.

Myeloablative busulfan/melphalan (BuMel) consolidation following induction chemotherapy for patients with high-risk neuroblastoma: A Children’s Oncology Group (COG) study.

Abstract Poster

Authors

null

Meaghan Granger

Cook Children's Health Care System, Fort Worth, TX

Meaghan Granger , Gregory A. Yanik , Arlene Naranjo , Jeannine S. McCune , Steven G. DuBois , Rochelle Bagatell , Brian D. Weiss , Stephan A. Grupp , Sheena Cretella Tenney , Shahab Asgharzadeh , Michael D. Hogarty , Joseph Ezra Panoff , John Han-Chih Chang , Julie M Gastier-Foster , Denise Mills , Julie R. Park

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Pediatric Oncology

Track

Pediatric Oncology

Sub Track

Pediatric Solid Tumors

Clinical Trial Registration Number

NCT01798004

Citation

J Clin Oncol 34, 2016 (suppl; abstr 10528)

DOI

10.1200/JCO.2016.34.15_suppl.10528

Abstract #

10528

Poster Bd #

219

Abstract Disclosures

Similar Posters

First Author: Joseph Allan Norton

First Author: Uday R. Popat

First Author: Elizabeth Sokol

First Author: Siddhi Ramesh